Bridging the gap between research, harm reduction, treatment and people living with hepatitis C
Hepatitis C is an easy to treat disease also with people who use drugs and other key populations. Elimination is possible with the necessary political wil. Harm reduction and community services play a crucial role in this setting.
The 3rd Hepatitis Community Summit will discuss these issues and brings together researcher, health and community workers, medical staff and HCV patients and advocates.
The Hepatitis C Community Summit launched a statement about the negative effects of criminalisation on health and well being of people who use drugs:
The decriminalisation of drug use and ensuring national funding of key services will reduce death, disease and marginalisation of people who use drugs
The meeting is organised by Correlation – European Harm Reduction Network in cooperation with the European Union funded Eurosider project, which is coordinated by the French research institute INSERM. The main objective of the Eurosider Project is to contribute to a better Hepatitis C policy and practice by developing the transferability of an effective community-based intervention to people who inject drugs in different political contexts with the aim to reduce the risk of HIV-HCV transmission.
Aides, Richard Stranz
Coalition Plus, Chase Perfect
C-EHRN, Eberhard Schatz
EATG, Marios Atzemis
EuroNPUD, Erin O’Mara
IDHDP, Sebastian Saville
INSERM, Perrine Roux, Caren Magan
Your contact information will only be stored for the purpose of sending information on the conference. Your personal data can be deleted at any time upon request.